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most severe anaphylactic reactions to food occur when
eating out in restaurants and cafes.10 Vulnerable people
are left with one of two options—either to take the risk of
asking about the ingredients of food and trusting in the
advice of catering staff, many of whom will have not
received any training in the dangers of food allergies, or
to curtail or completely avoid eating out. The European
Union should adopt the same requirements as Australa-
sia, where all food suppliers have to make available to
consumers detailed information on ingredients on the
packaging, or on a display alongside the food, or to the
purchaser on request.6
Furthermore, this EU legislation will do nothing
about the highly frustrating general warning “may
contain traces of nuts.”11 To protect people with food
allergies effectively, production lines for the main aller-
gens should be separated completely from other
production lines in factories and other settings for
processing and packaging food products. In the mean-
time, food suppliers should provide consumers with a
much clearer idea of the likelihood of trace exposure
to nuts and other products.
Policy makers, legislators, and food suppliers need
to appreciate that neither underplaying nor overplay-
ing the risks of exposure to allergenic foods are helpful
for those living with what is often a highly debilitating
lifelong condition. People with food allergies need
accurate, clear, and easily understood information to
make truly informed choices and to live with and con-
trol their condition with a sense of confidence.
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Primary care trusts: do they have a future?
Yes as guardians of public sector commissioning; no as service providers
Primary care trusts (PCTs) are the local statutoryorganisations in the English NHS responsible forimproving public health, providing primary
health care, and commissioning secondary and tertiary
care services for populations of around 250 000 people.
When created in 2002 primary care trusts were intended
to become powerful local purchasing agencies, rooted in
primary care, and well placed to integrate primary
health care, community services, and hospital care.1 In
the international context, one of the most notable
features of primary care trusts has been the continuing
belief by NHS policy makers in England in the value of
integrating the purchasing of health care with the deliv-
ery of primary care.However, over the past year or more
the view that primary care trusts are failing to “punch
their weight” in the health system has gained currency, in
particular in relation to their supposed inability to
achieve strategic change in secondary care.2–4
This has led to renewed interest in strengthening the
commissioning function in the NHS. The assumption is
that there will be fewer primary care trusts and that these
will concentrate on funding and contracting for primary
care, supporting the purchasing of other services led by
practice based commissioners, and divesting themselves
of their provider responsibilities such as community
nursing and health visiting.5 This is driven partly by the
perception of the trusts’ “failure” as commissioners. But
it is arguably driven more so by policy makers’
encouragement of a greater range of providers of
primary care beyond traditional NHS general practice6
and the planned roll out of practice based commission-
ing (a scheme whereby practices are delegated a
purchasing budget for their enrolled population) to all
general practices in England by the end of 2006.5
The recent encouragement of a more plural
primary care market, where patients can choose to
enrol with or use a greater range of providers as well as
conventional general practices, arguably represents the
strongest reason for a change to primary care trusts.
Practice based commissioning challenges their com-
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missioning role, and the development of a market in
primary care threatens their constitutional integrity. As
long as primary care was almost entirely provided by
practices owned by general practitioners operating to a
national NHS contract, the conflict of interest inherent
in having the commissioning function run by bodies
dominated by NHS general practitioners was manage-
able, justifiable, and arguably a strength. The
development of a market in primary care provision
requires that ultimate responsibility for local commis-
sioning should be undertaken by a body entirely sepa-
rate from all providers. Despite an apparent backtrack-
ing by policy makers about the need to remove
provider functions from primary care trusts, it is hard
to justify them having a continuing provider role in
what is clearly a primary care market.
However, the reintroduction of general practitioner
budget holding (in the guise of practice based commis-
sioning) appears to contradict this since it is intended
to increase general practitioners’ engagement in the
purchasing of services, facilitate a further shift of care
from acute to community settings, and provide a
demand management counterweight to the power of
the new, more autonomous foundation hospitals.7 Pri-
mary care trusts have to determine which practices can
take devolved purchasing responsibility—and ensure
that all practices are engaged in some commissioning
by the end of 2006.5 Primary care trusts also have to
find resources for new forms of management, informa-
tion, and analytical support for local practice based
commissioning.
A more pluralist yet still publicly financed health
system calls for stronger market development,
management, and regulation. While some elements of
these functions will fall to national bodies regulating
healthcare standards, patient safety, and levels of access
to and choice of care, a local body (with a more appro-
priate name) is still needed to act as both the local
“brain” in the system and its “conscience.” As brain it
needs to determine public health priorities, overall
resource allocation, and service design across primary
and secondary care; as its conscience it needs to assure
service quality, manage and oversee contracting on
behalf of practice based commissioners, govern
conflicts of interest, secure public involvement, and
assure probity in the use of public funds.
Recently, it has been argued that non-NHS bodies
should be eligible to become commissioners of NHS
care.8 In a publicly funded system, however, it seems
reasonable to assert that the brain and conscience
should be a public body, particularly in a mixed
economy of providers. That is not to say that elements
of commissioning cannot be contracted out to actuar-
ies, contracting specialists, and disease management
plans, and that some commissioning could be
delegated to private providers of primary care, but
rather that ultimate accountability for use of public
funds should remain with a public body.
So do PCTs have a future role? The answer is
unequivocally yes in relation to the need for stronger
strategic purchasers and governors of local health sys-
tems as detailed commissioning decisions pass to prac-
tices and perhaps in time to their private sector
competitors as well. But, as the primary care system
becomes increasingly diverse, they should no longer be
service providers. This leaves unresolved the question
of where current community health services such as
community nursing and public health will be relocated,
a conundrum that would seem to be yet another unin-
tended consequence of a policy shift towards a more
plural primary care market.
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The private health sector in India
Is burgeoning, but at the cost of public health care
Foreigners in increasing numbers are nowcoming to India for private health care. Theycome from the Middle East, Africa, Pakistan, and
Bangladesh, for complex paediatric cardiac surgery or
liver transplants—procedures that are not done in their
home countries. They also come from the United
Kingdom, Europe, and North America for quick,
efficient, and cheap coronary bypasses or orthopaedic
procedures. A shoulder operation in the UK would
cost £10 000 ($17 460; €14 560) done privately or
entail several months’ wait under the NHS. In India, the
same operation can be done for £1700 and within
10 days of a first email contact.1
The recent remarkable growth of the private health
sector in India has come at a time when public spend-
ing on health care at 0.9% of gross domestic product
(GDP) is among the lowest in the world and ahead of
only five countries—Burundi, Myanmar, Pakistan,
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